Ear3 Inhibitors
Ear3, predicted to enable ribonuclease activity and involved in various cellular functions, presents an intriguing target for scientific exploration. Its predicted roles in chemotaxis, innate immune response in mucosa, and extracellular space activities hint at its involvement in critical physiological processes. Furthermore, its orthology to human RNASE2 underscores its potential significance in the broader context of mammalian biology.
Understanding the general mechanisms of Ear3 inhibition reveals a complex interplay of cellular pathways targeted by specific chemical entities. These inhibitors act through diverse signaling cascades, such as the EGFR, NF-κB, actin-myosin contractility, thymidylate synthesis, PI3K/AKT, MAPK, mTOR, histone deacetylation, and JNK pathways, modulating the expression and activity of Ear3 indirectly. The inhibition is achieved by influencing downstream effectors, altering gene expression patterns, and perturbing the delicate balance of cellular signaling. This nuanced approach to inhibition reflects the intricacy of cellular regulation and provides valuable insights into potential strategies for manipulating Ear3 in controlled laboratory settings. The diverse chemical inhibitors, through their specific actions on various pathways, offer indispensable tools for scientific investigations aiming to decipher the intricate roles of Ear3 in cellular processes.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Erlotinib, Free Base | 183321-74-6 | sc-396113 sc-396113A sc-396113B sc-396113C sc-396113D | 500 mg 1 g 5 g 10 g 100 g | $87.00 $135.00 $293.00 $505.00 $3827.00 | 42 | |
Erlotinib, an EGFR inhibitor, disrupts the EGFR pathway, indirectly inhibiting Ear3 by altering downstream signaling and influencing gene expression within relevant cellular contexts. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
BAY 11-7082, an IKK inhibitor, interferes with the NF-κB pathway, influencing Ear3 expression by blocking the activation of transcription factors and subsequently impeding inflammatory responses. | ||||||
(±)-Blebbistatin | 674289-55-5 | sc-203532B sc-203532 sc-203532A sc-203532C sc-203532D | 5 mg 10 mg 25 mg 50 mg 100 mg | $183.00 $313.00 $464.00 $942.00 $1723.00 | 7 | |
Blebbistatin, a myosin II inhibitor, disrupts the actin-myosin contractility, indirectly impacting Ear3 by altering cellular morphology and influencing gene expression within relevant cellular contexts. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $37.00 $152.00 | 11 | |
Fluorouracil, a thymidylate synthase inhibitor, disrupts DNA synthesis, indirectly inhibiting Ear3 by inducing DNA damage and altering cellular processes related to gene expression. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002, a PI3K inhibitor, disrupts the PI3K/AKT pathway, indirectly influencing Ear3 by modulating downstream effectors and interfering with the regulation of gene expression in relevant cellular contexts. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580, a p38 MAPK inhibitor, modulates the MAPK pathway, impacting Ear3 indirectly by altering signaling cascades and gene expression within relevant cellular contexts. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin, an mTOR inhibitor, influences the mTOR pathway, indirectly inhibiting Ear3 by altering protein synthesis and cell cycle progression, leading to changes in gene expression within the cellular context. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A, a histone deacetylase inhibitor, epigenetically regulates gene expression, indirectly inhibiting Ear3 by modulating chromatin structure and transcriptional control within the cellular environment. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin, a PI3K inhibitor, disrupts the PI3K/AKT pathway, indirectly influencing Ear3 by modulating downstream effectors and interfering with the regulation of gene expression in relevant cellular contexts. | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $138.00 $380.00 | 101 | |
Cisplatin, a DNA cross-linking agent, disrupts DNA synthesis, indirectly inhibiting Ear3 by inducing DNA damage and altering cellular processes related to gene expression. | ||||||